Sale disclosed
Jill DeSimone
Director
Common Stock
- Reported value
- $3.01K
- Reported price
- $301.44 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Praxis Precision Medicines, Inc.
Last 30 daysNo qualifying insider buying. No qualifying insider sales.
Showing the first 6 of 12 trades on this page.
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Director | Common StockSale10b5-112 trades | 11,600avg $311.32 / share | $3.61M | Jun 24Filed Jun 26 · 2d later | 12 filings
|
Praxis Precision Medicines, Inc. - Common Stock (PRAX) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberNo eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.